Software provider Veeva Systems in Healthcare (Nasdaq: Veev) reported Q4 Cy2024 results that exceed the market sales expectations, with a turnover of 14.3% years after year up to $ 720.9 million. The company expects the turnover of the next quarter to be around $ 727.5 million, close to the estimates of analysts. The non-Gaap profit of $ 1.74 per share was 10.1% above the consensus estimates of analysts.
Is it time to buy Veeva systems? Discover it in our full research report.
-
Gain: $ 720.9 million versus analyst estimates of $ 699.1 million (14.3% on an annual basis, 3.1% beat)
-
Custom EPS: $ 1.74 versus analysts of $ 1.58 (10.1% beat)
-
Adapted business income: $ 307.7 million versus analyst estimates of $ 277.9 million (42.7% margin, 10.7% beat)
-
Management income guidance For the coming financial Year 2026 is $ 3.05 billion at the center, in accordance with the expectations of the analysts and the implication of a growth of 11% (versus 16.5% in FY2025)
-
Management Guidelines for commercial profit (Non-Gaap) For the coming financial Year 2026 is $ 1.30 billion at the center, above the expectations of the analysts
-
Business margin: 26.1%, an increase of 21.4% in the same quarter last year
-
Free cash flow margin: 9%, a decrease of 22.9% in the previous quarter
-
Market capitalization: $ 35.47 billion
“It was an excellent quarter and year of implementation and innovation in software, data and business advice,” said CEO Peter Gassner.
Veeva (NYSE: VEEV) is built on top of Salesforce as one of the first vertical targeted cloud platforms and offers data and CRM software for data and customer relationship management (CRM) for organizations in the Life Sciences industry.
The Coronavirus Pandemia has underlined the importance of high -quality health infrastructure in the crisis. In combination with intense competition between drug makers and the growing volume of data in the health care sector, the demand for data management solutions in health care is expected to be strong in the coming years.
The long -term performance of a company is an indicator of overall quality. Even a bad thing can shine one or two quarters, but a top class grows for years. In the past three years, Veeva Systems has grown its turnover with an annual percentage of 14.1%. Although this growth is acceptable on an absolute basis, it has not been brought to our standards for the software sector, which enjoys a number of secular instructions. Fortunately there are other things to like from Veeva systems.
This quarter, Veeva Systems reported revenue growth on an annual basis of 14.3%, and the $ 720.9 million in turnover exceeded Wall Street’s estimates by 3.1%. Business management is currently leading to an increase in the revenue increase of 11.9% on an annual basis next quarter.
